FDA Approves Imdelltra (tarlatamab-dlle) for Extensive Stage Small Cell Lung Cancer

2024-05-17T11:48:16-05:00May 17th, 2024|Hot Topics, News, Science and Research, Small Cell Lung Cancer|

On May 16, 2024, the U.S. Food and Drug Administration (FDA) granted Imdelltra (tarlatamab-dlle) accelerated approval for people with extensive stage small cell lung cancer (ES-SCLC) following progression on or after platinum-based chemotherapy. The approval is based on results [...]

ASCO Issues New Recommendation Cosela (Trilaciclib) in Update to its Treatment Guidelines for Small Cell Lung Cancer

2023-10-20T12:24:54-05:00October 20th, 2023|Hot Topics, News, Science and Research, Small Cell Lung Cancer|

On October 11, 2023, the American Society of Clinical Oncology (ASCO) recommended an update to its treatment guidelines for small cell lung cancer (SCLC). Cosela (trilaciclib) has been recommended as a myeloid supportive agent for individuals with extensive-stage SCLC who [...]

Finding Strength After a Small Cell Lung Cancer Diagnosis: Bob’s Story

2023-10-05T15:35:59-05:00October 3rd, 2023|Newsletter Articles, Small Cell Lung Cancer Spotlight, Spotlights, Stories of Hope, Your Community|

After spending over 20 years in the hospitality field, Bob Iles changed careers and joined the stock brokerage industry before retiring almost six years ago. He and his husband live in Palm Springs, CA, where he enjoys swimming in [...]

A New Lease on Life: Mike’s Story

2024-03-19T15:56:44-05:00September 15th, 2023|Hot Topics, Newsletter Articles, Small Cell Lung Cancer Spotlight, Spotlights, Stories of Hope, Survivors, Your Community|

By Mike Knecht   Mike Knecht retired from his career as an electrical contractor and business owner in 2019 and spent the following year traveling through the United States and Africa. In early 2023, he and his wife, Lois, sold their home in Maryland to live full-time in their vacation/retirement home in West [...]

Go to Top